Detailed information for compound 116376
Basic information
Technical information
- TDR Targets ID: 116376
- Name: 3-(4-aminophenyl)-3-cyclohexylpiperidine-2,6- dione
- MW: 286.369 | Formula: C17H22N2O2
-
H donors: 2
H acceptors: 2
LogP: 2.9
Rotable bonds: 2
Rule of 5 violations (Lipinski): 1 - SMILES: O=C1CCC(C(=O)N1)(C1CCCCC1)c1ccc(cc1)N
- InChi: 1S/C17H22N2O2/c18-14-8-6-13(7-9-14)17(12-4-2-1-3-5-12)11-10-15(20)19-16(17)21/h6-9,12H,1-5,10-11,18H2,(H,19,20,21)
- InChiKey: NTKWRAAWKFNECW-UHFFFAOYSA-N
Network
Hover on a compound node to display the structore
Synonyms
- 3-(4-aminophenyl)-3-cyclohexyl-piperidine-2,6-dione
- 3-(4-aminophenyl)-3-cyclohexyl-piperidine-2,6-quinone
- cyclohexylaminoglutethimide
- 115883-22-2
- 137548-41-5
- 2,6-Piperidinedione, 3-(4-aminophenyl)-3-cyclohexyl-
- 3-(4-Aminophenyl)-3-cyclohexyl-2,6-piperidinedione
- 3-Cyclohexyl-3-(4-aminophenyl)-2,6-piperidinedione
- ChAG
- (+-)-3-(4-Aminophenyl)-3-cyclohexyl-2,6-piperidinedione
- 2,6-Piperidinedione, 3-(4-aminophenyl)-3-cyclohexyl-, (+-)-
- Nphchexpipone
- 3-4-Aminophenyl;-3-cyclohexylpiperidine-2,6-dione
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Homo sapiens | thromboxane A synthase 1 (platelet) | Starlite/ChEMBL | References |
| Homo sapiens | cytochrome P450, family 19, subfamily A, polypeptide 1 | Starlite/ChEMBL | References |
Predicted pathogen targets for this compound
By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
| Species | Potential target | Known druggable target | Length | Alignment span | Identity |
|---|---|---|---|---|---|
| Trypanosoma cruzi | cytochrome P450, putative | cytochrome P450, family 19, subfamily A, polypeptide 1 | 503 aa | 425 aa | 18.8 % |
| Trypanosoma brucei | cytochrome P450, putative | thromboxane A synthase 1 (platelet) | 534 aa | 498 aa | 21.5 % |
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Echinococcus multilocularis | thymidine phosphorylase | 0.3436 | 1 | 0.5 |
| Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.097 | 0 | 0.5 |
| Mycobacterium ulcerans | thymidine phosphorylase | 0.3436 | 1 | 1 |
| Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.3436 | 1 | 1 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| IC50 (binding) | = 0.15 uM | Inhibition of thromboxane synthase P450 TXA2 | ChEMBL. | 11087568 |
| IC50 (binding) | = 0.15 uM | Concentration of the compound inhibiting Aromatase | ChEMBL. | 1613747 |
| IC50 (binding) | = 0.15 uM | Inhibition of thromboxane synthase P450 TXA2 | ChEMBL. | 11087568 |
| IC50 (binding) | = 0.15 uM | Concentration of the compound inhibiting Aromatase | ChEMBL. | 1613747 |
| IC50 (binding) | = 0.3 uM | Concentration of the compound inhibiting Aromatase | ChEMBL. | 1613747 |
| IC50 (binding) | = 0.3 uM | Concentration of the compound inhibiting Aromatase | ChEMBL. | 1613747 |
| IC50 (binding) | = 4.6 uM | Concentration of the compound inhibiting Aromatase | ChEMBL. | 1613747 |
| IC50 (binding) | = 4.6 uM | Concentration of the compound inhibiting Aromatase | ChEMBL. | 1613747 |
| IC50 (binding) | = 67 uM | Inhibition of bovine adrenal desmolase | ChEMBL. | 1613747 |
| IC50 (binding) | = 67 uM | Inhibition of bovine adrenal desmolase | ChEMBL. | 1613747 |
| IC50 (binding) | = 82 uM | Inhibition of bovine adrenal desmolase | ChEMBL. | 1613747 |
| IC50 (binding) | = 82 uM | Inhibition of bovine adrenal desmolase | ChEMBL. | 1613747 |
| Inhibition (binding) | = 19 % | Inhibition of bovine adrenal desmolase at 25 uM | ChEMBL. | 1613747 |
| Inhibition (binding) | = 19 % | Inhibition of bovine adrenal desmolase at 25 uM | ChEMBL. | 1613747 |
| Inhibition (binding) | = 31 % | Inhibition of bovine adrenal desmolase at 25 uM | ChEMBL. | 1613747 |
| Inhibition (binding) | = 31 % | Inhibition of bovine adrenal desmolase at 25 uM | ChEMBL. | 1613747 |
| Inhibition (binding) | = 39 % | Inhibition of bovine adrenal desmolase at 25 uM | ChEMBL. | 1613747 |
| Inhibition (binding) | = 39 % | Inhibition of bovine adrenal desmolase at 25 uM | ChEMBL. | 1613747 |
| Relative potency (binding) | = 8 | Inhibition of cytochrome P450 Aromatase (IC50) relative to aminoglutethimide | ChEMBL. | 1613747 |
| Relative potency (binding) | = 123 | Inhibition of cytochrome P450 Aromatase (IC50) relative to aminoglutethimide | ChEMBL. | 1613747 |
| Relative potency (binding) | = 240 | Inhibition of cytochrome P450 Aromatase (IC50) relative to aminoglutethimide | ChEMBL. | 1613747 |
| Relative potency (binding) | = 0.3 | Inhibition of bovine adrenal desmolase (IC50) relative to aminoglutethimide | ChEMBL. | 1613747 |
| Relative potency (binding) | = 0.4 | Inhibition of bovine adrenal desmolase (IC50) relative to aminoglutethimide | ChEMBL. | 1613747 |
| Relative potency (binding) | = 8 | Inhibition of cytochrome P450 Aromatase (IC50) relative to aminoglutethimide | ChEMBL. | 1613747 |
| Relative potency (binding) | = 123 | Inhibition of cytochrome P450 Aromatase (IC50) relative to aminoglutethimide | ChEMBL. | 1613747 |
| Relative potency (binding) | = 240 | Inhibition of cytochrome P450 Aromatase (IC50) relative to aminoglutethimide | ChEMBL. | 1613747 |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- Search by CAS
- Search by CAS
- ChEMBL: CHEMBL70901
- PubChem: 126253
Bibliographic References
2 literature references were collected for this gene.
If you have references for this compound, please enter them in a user comment (below) or Contact us.